NYSE : BIO
Bio-Rad Laboratories, Inc. — Financial statements
Healthcare · Medical Devices · United States
Last price 384.4 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 10.28B
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Financial statements
Bio-Rad Laboratories, Inc. (BIO) reported revenue of 2.59B USD (TTM). Five years of income statement, balance sheet, cash flow and ratios below.
Income statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Revenue | 2.59B | 2.58B | 2.57B | 2.67B | 2.80B | 2.92B |
| Cost of Revenue | 1.24B | 1.24B | 1.17B | 1.24B | 1.23B | 1.26B |
| Gross Profit | 1.35B | 1.34B | 1.39B | 1.43B | 1.57B | 1.66B |
| Selling, General & Admin | 827.50M | 819.80M | 810.20M | 824.20M | 827.80M | 851.02M |
| Research & Development | 247.70M | 257.60M | 294.30M | 240.90M | 256.90M | 247.34M |
| Operating Expenses | 1.08B | 1.08B | 1.10B | 1.07B | 1.08B | 1.10B |
| Operating Income | 272.30M | 266.20M | 289.20M | 365.70M | 482.60M | 564.74M |
| Interest Expense | -48.80M | -49.00M | -48.90M | -49.40M | -38.10M | -1.55M |
| Interest & Investment Income | 87.90M | 95.50M | 82.00M | 100.90M | 58.10M | 18.90M |
| Currency Exchange Gain (Loss) | 7.60M | 6.60M | 3.90M | 7.30M | 200.00K | -2.75M |
| Other Non Operating Income (Expenses) | -200.00K | -300.00K | 3.20M | 4.90M | -5.20M | 675.00K |
| EBT Excluding Unusual Items | 318.80M | 319.00M | 329.40M | 429.40M | 497.60M | 580.01M |
| Merger & Restructuring Charges | -46.10M | -46.10M | -21.80M | -27.90M | -64.40M | |
| Gain (Loss) on Sale of Investments | 250.50M | 895.40M | -2.65B | -1.25B | -5.20B | 4.93B |
| Gain (Loss) on Sale of Assets | 1.40M | |||||
| Asset Writedown | -172.80M | -172.80M | ||||
| Pretax Income | 350.40M | 995.50M | -2.34B | -850.10M | -4.70B | 5.45B |
| Income Tax Expense | 128.00M | 235.60M | -498.30M | -212.80M | -1.08B | 1.19B |
| Net Income | 222.40M | 759.90M | -1.84B | -637.30M | -3.63B | 4.25B |
| Net Income to Common | 222.40M | 759.90M | -1.84B | -637.30M | -3.63B | 4.25B |
| Shares Outstanding (Basic) | 26.92M | 27.28M | 28.21M | 29.21M | 29.79M | 29.83M |
| Shares Outstanding (Diluted) | 26.92M | 27.28M | 28.21M | 29.21M | 29.79M | 30.21M |
| EPS (Basic) | 8.26 | 27.85 | -65.36 | -21.82 | -121.79 | 142.61 |
| EPS (Diluted) | 8.26 | 27.85 | -65.36 | -21.82 | -121.79 | 140.83 |
| Free Cash Flow | 353.10M | 374.60M | 289.60M | 218.20M | 81.60M | 535.75M |
| Free Cash Flow Per Share | 13.12 | 13.73 | 10.26 | 7.47 | 2.74 | 17.74 |
| Gross Margin | 52.04% | 52.01% | 54.30% | 53.56% | 55.93% | 56.91% |
| Operating Margin | 10.52% | 10.30% | 11.27% | 13.69% | 17.22% | 19.32% |
| Profit Margin | 8.59% | 29.42% | -71.86% | -23.86% | -129.45% | 145.57% |
| Free Cash Flow Margin | 13.64% | 14.50% | 11.28% | 8.17% | 2.91% | 18.33% |
| EBITDA | 441.00M | 431.60M | 440.80M | 511.60M | 619.90M | 702.34M |
| EBITDA Margin | 17.03% | 16.71% | 17.18% | 19.15% | 22.12% | 24.03% |
| D&A For EBITDA | 168.70M | 165.40M | 151.60M | 145.90M | 137.30M | 137.60M |
| EBIT | 272.30M | 266.20M | 289.20M | 365.70M | 482.60M | 564.74M |
| EBIT Margin | 10.52% | 10.30% | 11.27% | 13.69% | 17.22% | 19.32% |
| Effective Tax Rate | 36.53% | 23.67% | 21.93% |
Balance sheet
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | 517.00M | 529.80M | 488.10M | 403.80M | 434.21M | 470.78M |
| Short-Term Investments | 1.10B | 1.01B | 1.18B | 1.20B | 1.36B | 399.13M |
| Cash & Short-Term Investments | 1.62B | 1.54B | 1.66B | 1.61B | 1.79B | 869.92M |
| Accounts Receivable | 441.80M | 460.60M | 452.50M | 489.00M | 494.64M | 423.54M |
| Other Receivables | 8.90M | 11.90M | 13.10M | 11.90M | 11.60M | 2.20M |
| Receivables | 450.70M | 472.50M | 465.60M | 500.90M | 506.25M | 425.74M |
| Inventory | 780.60M | 740.70M | 760.00M | 780.50M | 719.32M | 572.24M |
| Prepaid Expenses | 147.80M | 136.50M | 122.60M | 140.00M | 124.18M | 109.14M |
| Restricted Cash | 1.60M | 2.00M | 1.40M | 200.00K | 13.00K | 14.00K |
| Other Current Assets | 21.30M | 13.80M | 16.20M | 19.60M | 17.55M | 13.44M |
| Total Current Assets | 3.02B | 2.91B | 3.03B | 3.05B | 3.16B | 1.99B |
| Property, Plant & Equipment | 671.90M | 709.90M | 688.60M | 723.70M | 679.56M | 716.44M |
| Long-Term Investments | 5.72B | 6.10B | 4.84B | 7.70B | 8.83B | 14.39B |
| Goodwill | 574.30M | 579.80M | 410.50M | 413.60M | 406.49M | 347.34M |
| Other Intangible Assets | 160.00M | 174.30M | 293.60M | 320.50M | 332.15M | 253.94M |
| Other Long-Term Assets | 102.70M | 103.80M | 103.50M | 96.40M | 95.80M | 105.49M |
| Total Assets | 10.25B | 10.58B | 9.36B | 12.30B | 13.50B | 17.80B |
| Accounts Payable | 143.50M | 129.00M | 122.30M | 144.60M | 135.04M | 141.94M |
| Accrued Expenses | 150.50M | 172.30M | 124.20M | 139.90M | 194.79M | 312.97M |
| Current Portion of Long-Term Debt | 400.20M | 800.00K | 800.00K | |||
| Current Portion of Leases | 34.10M | 36.60M | 42.10M | 40.90M | 36.80M | 36.92M |
| Current Income Taxes Payable | 74.20M | 36.60M | 31.20M | 35.80M | 32.43M | 10.32M |
| Current Unearned Revenue | 52.50M | 48.90M | 47.80M | 50.85M | ||
| Other Current Liabilities | 106.30M | 92.80M | 99.40M | 161.60M | 169.65M | 127.94M |
| Total Current Liabilities | 961.30M | 517.00M | 467.80M | 522.80M | 568.71M | 680.94M |
| Long-Term Debt | 794.60M | 1.19B | 1.19B | 1.19B | 1.19B | 3.00K |
| Long-Term Leases | 141.50M | 154.40M | 140.60M | 175.10M | 163.73M | 186.45M |
| Long-Term Unearned Revenue | 13.50M | 14.00M | 13.70M | |||
| Pension & Post-Retirement Benefits | 49.20M | 56.90M | 59.50M | 45.30M | 73.80M | |
| Long-Term Deferred Tax Liabilities | 982.20M | 1.06B | 818.00M | 1.48B | 1.77B | 3.06B |
| Other Long-Term Liabilities | 185.00M | 135.90M | 106.60M | 135.50M | 150.61M | 108.39M |
| Total Liabilities | 3.08B | 3.12B | 2.79B | 3.56B | 3.89B | 4.11B |
| Common Stock | 3.00K | 3.00K | ||||
| Additional Paid-In Capital | 502.90M | 476.00M | 463.20M | 449.10M | 447.45M | 441.73M |
| Retained Earnings | 8.02B | 8.18B | 7.42B | 9.26B | 9.90B | 13.53B |
| Treasury Stock | -1.08B | -1.01B | -772.10M | -632.50M | -263.59M | -106.29M |
| Comprehensive Income & Other | -271.30M | -189.10M | -538.20M | -336.00M | -466.82M | -175.55M |
| Shareholders' Equity | 7.17B | 7.45B | 6.57B | 8.74B | 9.62B | 13.69B |
| Total Liabilities & Equity | 10.25B | 10.58B | 9.36B | 12.30B | 13.50B | 17.80B |
| Total Debt | 1.37B | 1.38B | 1.37B | 1.41B | 1.39B | 223.38M |
| Net Cash (Debt) | 248.10M | 155.90M | 289.80M | 201.60M | 402.56M | 646.54M |
| Net Cash Per Share | 9.22 | 5.71 | 10.27 | 6.90 | 13.52 | 21.40 |
| Filing Date Shares Outstanding | 26.74M | 26.99M | 28.01M | 28.52M | 29.60M | 29.93M |
| Total Common Shares Outstanding | 26.74M | 26.99M | 28.01M | 28.52M | 29.60M | 29.93M |
| Working Capital | 2.06B | 2.39B | 2.56B | 2.53B | 2.59B | 1.31B |
| Book Value Per Share | 268.30 | 276.16 | 234.52 | 306.51 | 324.89 | 457.20 |
| Tangible Book Value | 6.44B | 6.70B | 5.87B | 8.01B | 8.88B | 13.08B |
| Tangible Book Value Per Share | 240.84 | 248.22 | 209.39 | 280.77 | 299.93 | 437.12 |
| Land | 28.90M | 27.80M | 28.40M | 27.80M | 27.94M | |
| Buildings | 449.40M | 426.30M | 419.80M | 393.60M | 385.80M | |
| Machinery | 1.32B | 1.18B | 1.15B | 1.09B | 1.10B |
Cash flow statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Net Income | 222.40M | 759.90M | -1.84B | -637.30M | -3.63B | 4.25B |
| Depreciation & Amortization | 168.70M | 165.40M | 151.60M | 145.90M | 137.30M | 137.60M |
| Loss (Gain) From Sale of Assets | -2.50M | -1.40M | ||||
| Asset Writedown & Restructuring Costs | 172.80M | 172.80M | 29.50M | |||
| Loss (Gain) From Sale of Investments | -248.00M | -894.40M | 2.66B | 1.25B | 5.21B | -4.93B |
| Stock-Based Compensation | 60.30M | 58.00M | 62.30M | 61.30M | 60.90M | 51.20M |
| Other Operating Activities | -6.60M | -3.30M | 20.00M | -12.00M | 22.10M | 8.74M |
| Change in Accounts Receivable | 21.30M | 19.60M | 16.20M | 11.40M | -87.40M | -20.40M |
| Change in Inventory | 27.50M | 68.90M | 8.50M | -46.30M | -158.80M | 46.10M |
| Change in Accounts Payable | -8.50M | -100.00K | -40.90M | -51.80M | -94.20M | 69.90M |
| Change in Income Taxes | 51.70M | 1.50M | 24.10M | -21.30M | -1.20M | -28.80M |
| Change in Other Net Operating Assets | -15.00M | 12.00M | -1.90M | -2.20M | -26.80M | -8.60M |
| Operating Cash Flow | 492.60M | 532.20M | 455.20M | 374.90M | 194.40M | 669.50M |
| Capital Expenditures | -139.50M | -157.60M | -165.60M | -156.70M | -112.80M | -133.75M |
| Sale of Property, Plant & Equipment | 100.00K | 100.00K | 200.00K | 200.00K | 52.00K | |
| Cash Acquisitions | -700.00K | -218.50M | -100.70M | -125.52M | ||
| Divestitures | 2.50M | 1.40M | ||||
| Sale (Purchase) of Intangibles | -23.40M | -1.50M | ||||
| Investment in Securities | -96.90M | 186.30M | 28.70M | 174.20M | -994.20M | -84.73M |
| Investing Cash Flow | -237.10M | -189.70M | -160.20M | 20.20M | -1.21B | -797.38M |
| Long-Term Debt Issued | 1.19B | |||||
| Long-Term Debt Repaid | -500.00K | -400.00K | -500.00K | -500.00K | -3.02M | |
| Net Debt Issued (Repaid) | -500.00K | -500.00K | -400.00K | -500.00K | 1.19B | -3.02M |
| Issuance of Common Stock | 14.90M | 15.80M | 19.20M | 18.50M | 17.60M | 20.63M |
| Repurchase of Common Stock | -135.70M | -298.50M | -207.00M | -443.60M | -229.70M | -72.48M |
| Other Financing Activities | 500.00K | -30.60M | -561.00K | |||
| Financing Cash Flow | -120.80M | -283.20M | -218.80M | -425.60M | 973.60M | -55.43M |
| Foreign Exchange Rate Adjustments | 12.40M | -16.90M | 9.20M | 400.00K | 3.00M | -12.64M |
| Miscellaneous Cash Flow Adjustments | -36.00K | |||||
| Net Cash Flow | 147.10M | 42.40M | 85.40M | -30.10M | -36.60M | -195.98M |
| Free Cash Flow | 353.10M | 374.60M | 289.60M | 218.20M | 81.60M | 535.75M |
| Free Cash Flow Margin | 13.64% | 14.50% | 11.28% | 8.17% | 2.91% | 18.33% |
| Free Cash Flow Per Share | 13.12 | 13.73 | 10.26 | 7.47 | 2.74 | 17.74 |
| Levered Free Cash Flow | 283.19M | 256.55M | 193.49M | 124.28M | 2.86M | 485.98M |
| Unlevered Free Cash Flow | 313.69M | 287.18M | 224.05M | 155.16M | 26.68M | 486.95M |
| Cash Income Tax Paid | 29.80M | 61.60M | 99.40M | 129.60M | 158.30M | 134.68M |
| Change in Working Capital | 121.60M | 272.40M | -620.80M | -432.80M | -1.61B | 1.14B |
Ratios
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Market Capitalization | 9.95B | 8.21B | 9.18B | 9.40B | 12.46B | 22.44B |
| Enterprise Value | 9.70B | 8.19B | 8.95B | 9.05B | 11.99B | 21.33B |
| Last Close Price | 372.18 | 302.99 | 328.51 | 322.89 | 420.49 | 755.57 |
| PE Ratio | 45.08 | 10.81 | 5.28 | |||
| Forward PE | 40.69 | 28.94 | 28.85 | 26.51 | 28.66 | 59.87 |
| PS Ratio | 3.84 | 3.18 | 3.58 | 3.52 | 4.45 | 7.68 |
| PB Ratio | 1.39 | 1.10 | 1.40 | 1.07 | 1.30 | 1.64 |
| P/TBV Ratio | 1.55 | 1.23 | 1.57 | 1.17 | 1.40 | 1.72 |
| P/FCF Ratio | 28.18 | 21.92 | 31.71 | 43.08 | 152.70 | 41.88 |
| P/OCF Ratio | 20.20 | 15.43 | 20.17 | 25.07 | 64.10 | 33.52 |
| PEG Ratio | 2.29 | 2.40 | 6.63 | 2.71 | 4.28 | |
| EV/Sales Ratio | 3.75 | 3.17 | 3.49 | 3.39 | 4.28 | 7.30 |
| EV/EBITDA Ratio | 22.00 | 18.97 | 20.30 | 17.68 | 19.34 | 30.37 |
| EV/EBIT Ratio | 35.63 | 30.76 | 30.94 | 24.74 | 24.84 | 37.77 |
| EV/FCF Ratio | 27.48 | 21.86 | 30.90 | 41.46 | 146.93 | 39.81 |
| Debt / Equity Ratio | 0.19 | 0.19 | 0.21 | 0.16 | 0.14 | 0.02 |
| Debt / EBITDA Ratio | 2.69 | 2.78 | 2.69 | 2.44 | 2.05 | 0.30 |
| Debt / FCF Ratio | 3.88 | 3.70 | 4.75 | 6.44 | 17.01 | 0.42 |
| Net Debt / Equity Ratio | -0.04 | -0.02 | -0.04 | -0.02 | -0.04 | -0.05 |
| Net Debt / EBITDA Ratio | -0.56 | -0.36 | -0.66 | -0.39 | -0.65 | -0.92 |
| Net Debt / FCF Ratio | -0.70 | -0.42 | -1.00 | -0.92 | -4.93 | -1.21 |
| Asset Turnover | 0.25 | 0.26 | 0.24 | 0.21 | 0.18 | 0.19 |
| Inventory Turnover | 1.57 | 1.65 | 1.52 | 1.65 | 1.91 | 2.11 |
| Quick Ratio | 2.15 | 3.89 | 4.55 | 4.03 | 4.04 | 1.90 |
| Current Ratio | 3.14 | 5.62 | 6.48 | 5.83 | 5.55 | 2.92 |
| Return on Equity (ROE) | 3.11% | 10.84% | -24.09% | -6.94% | -31.14% | 36.11% |
| Return on Assets (ROA) | 1.66% | 1.67% | 1.67% | 1.77% | 1.93% | 2.29% |
| Return on Invested Capital (ROIC) | 2.54% | 2.99% | 3.90% | 4.12% | 4.34% | 3.98% |
| Return on Capital Employed (ROCE) | 2.90% | 2.60% | 3.30% | 3.10% | 3.70% | 3.30% |
| Earnings Yield | 2.22% | 9.25% | -20.08% | -6.78% | -29.11% | 18.96% |
| FCF Yield | 3.55% | 4.56% | 3.15% | 2.32% | 0.66% | 2.39% |
| Buyback Yield / Dilution | 3.11% | 3.31% | 3.41% | 1.93% | 1.40% | -0.16% |